Jump Financial’s RAPT Therapeutics RAPT Stock Holding History

Jump Financial’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,845	Closed	-$333K	–	2316
2025 Q4	$333K	Buy	+9,845	New	+$306K	﹤0.01%	1494
2024 Q2	–	Sell	-6,438	Closed	-$462K	–	2173
2024 Q1	$462K	Buy	+6,438	New	+$895K	0.01%	1222
2023 Q2	–	Sell	-4,214	Closed	-$619K	–	2096
2023 Q1	$619K	Buy	+4,214	New	+$852K	0.03%	797
2021 Q4	–	Sell	-3,497	Closed	-$869K	–	1654
2021 Q3	$869K	Buy	+3,497	New	+$925K	0.06%	325
2021 Q1	–	Sell	-1,620	Closed	-$256K	–	1221
2020 Q4	$256K	Buy	+1,620	New	+$352K	0.04%	662

Jump Financial's RAPT Position: Q1 2026 in Review

Jump Financial sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 9,845 shares — an estimated $333K sold.

Jump Financial first reported a position in RAPT in Q4 2020 and held it in 5 quarters. The position peaked at $869K in Q3 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Jump Financial reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Jump Financial sold 9,845 RAPT Therapeutics shares in Q1 2026, an estimated $333K.
Jump Financial first reported a position in RAPT Therapeutics in Q4 2020 and held it in 5 quarters.
Jump Financial's RAPT Therapeutics position peaked at $869K in Q3 2021.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.